Carolina Alarco

Miami Biotech Collective is South Florida’s largest and most influential community of biotech leaders — bringing together CEOs, founders, investors, academic institutions and the public sector. United by a shared mission, we exist to cultivate high-value relationships, unlock opportunities, and accelerate the growth of the region’s biotech sector. Our goal is to make Greater Miami a global biotech destination. We connect people, sharing resources, and supporting strategic initiatives. In doing so, we’re creating an environment where companies, careers and innovators thrive — and where biotech has the power to shape the region’s future. Amplify your impact. Meet interesting people. Join us CLICK HERE TO SIGN UP--> https://forms.gle/TWWcaBtthRdXCiAX9

Our Mission is to turn INNOVATIVE science into more accurate and affordable therapies for patients worldwide through In VITRO 3D solutions, envisioning the creation of technologies that accelerate drug development, enhancing new therapies efficacy to bring new HOPES to humankind, preferably reducing costs and reducing or even avoiding the need for animal models use. Our 3D human models are self-assembled and Matrigel-free, setting us apart from our competitors. Our 3D human models are morpho-functionally validated compared to classic 2D models widespread in drug discovery and development. In addition, we provide consulting in 3D technologies and confocal and high throughput microscope imaging focused on morphological and functional characterization of 3D models. OUR PORTFOLIO FOR ADIPOSE TISSUE INCLUDES: - Models derived from human adult cells. Stromal vascular fraction, SFV of both subcutaneous and visceral fat depots, the latter an exclusive product that sets us apart in the market. - Bonds Bio 3D human Adipose Tissue organoids in the most advanced platform to access mitochondrial respiration (OCR) and glycolysis (ECAR) (3D Seahorse plates - Seahorse, Agilent) ready to treat and read. - 2D-to-3D transition kits containing 96-well plates with 3D progenitor organoids and 96-well plates with 2D progenitor cells in a monolayer to run Bonds Bio Adipose Tissue differentiation protocol in parallel (Subcutaneous or Visceral). This transition kit is for you who need an extra layer of confidence before a complete transition to Bonds Bio 3D human mature organoids. We provide our organoids in 96- and 384-well plates, with individual organoids per well, an outstanding source of unique feature samples for your testing, allowing for mid-to-large scale analysis and compatible with the most common high-throughput systems available in the market. If you want to be a part of this revolution of in vitro biology, do not hesitate to contact us at bondsbio.com/contact

TBD Angels is a group of angel investors who are current operators at leading startups and executives at major companies.I We are committed to extending our early-stage financial investments beyond that of a commodity: As recovering / current entrepreneurs and leaders passionate about helping early stage ventures, we strive to share our deep and varied experiences in operating startup ventures. We look forward to lending a helping hand to entrepreneurs on a path to change the world!

Lifespan.io is a non profit education and advocacy organization. We promote advancement of biomedical technologies which can increase healthy human lifespan and seek to raise awareness regarding related societal benefits. Our website also enables the public to interact with and crowdfund longevity research initiatives.

Dione Antibiotics, Inc. is an early-stage biopharmaceutical company uniquely positioned to develop a new class of proprietary small molecule compounds against a new essential target to treat deadly drug-resistant superbug bacterial pandemic infections.

SYTE.bio is a Synthetic Biology Start-Up company developing precision DNA & RNA-based therapeutics and vaccines. The company has been incorporated as a Delaware C Corp in 2021 (SYTE.bio, Inc), and has labs & offices in Argentinas headquarter, that has been operating since 2017. SYTE.bio is pioneering the development of life-changing treatments for severe diseases and vaccines to treat and prevent diseases at the molecular and cellular level using engineered DNA, improving life through innovation. SYTE.bio’s powerful redosable DNA & RNA delivery platforms will unleash the potential of personalized genetic medicine in multiple potential applications, such as Gene Therapy (Oncology, Monogenic Diseases, Cardiovascular Diseases, Vaccines, Orphan Diseases), Cell Therapy (CAR-T Therapy, Induced Pluripotent Stem Cells (iPSC)) and Gene Editing (CRISPR/Cas, TALEN, ZFN).

Miami Biotech Collective is South Florida’s largest and most influential community of biotech leaders — bringing together CEOs, founders, investors, academic institutions and the public sector. United by a shared mission, we exist to cultivate high-value relationships, unlock opportunities, and accelerate the growth of the region’s biotech sector. Our goal is to make Greater Miami a global biotech destination. We connect people, sharing resources, and supporting strategic initiatives. In doing so, we’re creating an environment where companies, careers and innovators thrive — and where biotech has the power to shape the region’s future. Amplify your impact. Meet interesting people. Join us CLICK HERE TO SIGN UP--> https://forms.gle/TWWcaBtthRdXCiAX9

Our Mission is to turn INNOVATIVE science into more accurate and affordable therapies for patients worldwide through In VITRO 3D solutions, envisioning the creation of technologies that accelerate drug development, enhancing new therapies efficacy to bring new HOPES to humankind, preferably reducing costs and reducing or even avoiding the need for animal models use. Our 3D human models are self-assembled and Matrigel-free, setting us apart from our competitors. Our 3D human models are morpho-functionally validated compared to classic 2D models widespread in drug discovery and development. In addition, we provide consulting in 3D technologies and confocal and high throughput microscope imaging focused on morphological and functional characterization of 3D models. OUR PORTFOLIO FOR ADIPOSE TISSUE INCLUDES: - Models derived from human adult cells. Stromal vascular fraction, SFV of both subcutaneous and visceral fat depots, the latter an exclusive product that sets us apart in the market. - Bonds Bio 3D human Adipose Tissue organoids in the most advanced platform to access mitochondrial respiration (OCR) and glycolysis (ECAR) (3D Seahorse plates - Seahorse, Agilent) ready to treat and read. - 2D-to-3D transition kits containing 96-well plates with 3D progenitor organoids and 96-well plates with 2D progenitor cells in a monolayer to run Bonds Bio Adipose Tissue differentiation protocol in parallel (Subcutaneous or Visceral). This transition kit is for you who need an extra layer of confidence before a complete transition to Bonds Bio 3D human mature organoids. We provide our organoids in 96- and 384-well plates, with individual organoids per well, an outstanding source of unique feature samples for your testing, allowing for mid-to-large scale analysis and compatible with the most common high-throughput systems available in the market. If you want to be a part of this revolution of in vitro biology, do not hesitate to contact us at bondsbio.com/contact

E2MC (Earth-to-Mars Capital) invests in space companies globally (except strategic competitors of the United States) starting from the pre-seed stage.

MassBio, a not-for-profit organization that represents and provides services and support for the Massachusetts life sciences industry, is the nations oldest biotechnology trade association. Founded in 1985, MassBio is committed to advancing Massachusetts​ leadership in the life sciences to grow the industry, add value to the healthcare system and improve patient lives. Representing more than 1000 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and healthcare, MassBio works to advance policy and promote education, while providing member programs and events, industry information, and services.

TBD Angels is a group of angel investors who are current operators at leading startups and executives at major companies.I We are committed to extending our early-stage financial investments beyond that of a commodity: As recovering / current entrepreneurs and leaders passionate about helping early stage ventures, we strive to share our deep and varied experiences in operating startup ventures. We look forward to lending a helping hand to entrepreneurs on a path to change the world!